HomeStudiesA clinical trial assessing the safety and efficacy...PositiveClinical Trial2010A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose studyView StudyView PDFClassification ResultsAI ClassificationPositiveFine-tuned ClassificationPositiveConditions StudiedObesityRelated StudiesPositive